欧美最新另类人妖I国产成人av一区二区三区在线观看I九九热精品视频在线观看I国产精品日韩在线I激情av五月婷婷I日韩精品免费

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Escherichia coli O8 Periplasmic nitrate reductase (napA) CSB-YP483414EOO
CSB-EP483414EOO
CSB-BP483414EOO
CSB-MP483414EOO
CSB-EP483414EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Undecaprenyl phosphate-alpha-4-amino-4-deoxy-L-arabinose arabinosyl transferase (arnT), partial CSB-YP483415EOO
CSB-EP483415EOO
CSB-BP483415EOO
CSB-MP483415EOO
CSB-EP483415EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 NADH-quinone oxidoreductase subunit N (nuoN), partial CSB-YP483416EOO
CSB-EP483416EOO
CSB-BP483416EOO
CSB-MP483416EOO
CSB-EP483416EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase (metE) CSB-YP483417EOO
CSB-EP483417EOO
CSB-BP483417EOO
CSB-MP483417EOO
CSB-EP483417EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Der GTPase-activating protein YihI (yihI) CSB-YP483418EOO
CSB-EP483418EOO
CSB-BP483418EOO
CSB-MP483418EOO
CSB-EP483418EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Quinolinate synthase A (nadA) CSB-YP483419EOO
CSB-EP483419EOO
CSB-BP483419EOO
CSB-MP483419EOO
CSB-EP483419EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Fatty acid oxidation complex subunit alpha (fadJ) CSB-YP483420EOO
CSB-EP483420EOO
CSB-BP483420EOO
CSB-MP483420EOO
CSB-EP483420EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Cell division protein ZipA homolog (zipA), partial CSB-YP483421EOO
CSB-EP483421EOO
CSB-BP483421EOO
CSB-MP483421EOO
CSB-EP483421EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 L-rhamnose isomerase (rhaA) CSB-YP483422EOO
CSB-EP483422EOO
CSB-BP483422EOO
CSB-MP483422EOO
CSB-EP483422EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 CDP-diacylglycerol pyrophosphatase (cdh), partial CSB-YP483423EOO
CSB-EP483423EOO
CSB-BP483423EOO
CSB-MP483423EOO
CSB-EP483423EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 50S ribosomal protein L31 (rpmE) CSB-YP483424EOO
CSB-EP483424EOO
CSB-BP483424EOO
CSB-MP483424EOO
CSB-EP483424EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 tRNA (uracil (54)-C (5))-methyltransferase CSB-YP483425EOO
CSB-EP483425EOO
CSB-BP483425EOO
CSB-MP483425EOO
CSB-EP483425EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 DNA-directed RNA polymerase subunit beta (rpoB), partial CSB-YP483426EOO
CSB-EP483426EOO
CSB-BP483426EOO
CSB-MP483426EOO
CSB-EP483426EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Molybdenum cofactor biosynthesis protein A (moaA) CSB-YP483427EOO
CSB-EP483427EOO
CSB-BP483427EOO
CSB-MP483427EOO
CSB-EP483427EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Putative transport protein YbjL (ybjL), partial CSB-YP483428EOO
CSB-EP483428EOO
CSB-BP483428EOO
CSB-MP483428EOO
CSB-EP483428EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 UPF0370 protein ypfN (ypfN), partial CSB-YP483429EOO
CSB-EP483429EOO
CSB-BP483429EOO
CSB-MP483429EOO
CSB-EP483429EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Ribosomal RNA large subunit methyltransferase N (rlmN) CSB-YP483430EOO
CSB-EP483430EOO
CSB-BP483430EOO
CSB-MP483430EOO
CSB-EP483430EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Phosphomethylpyrimidine synthase (thiC) CSB-YP483431EOO
CSB-EP483431EOO
CSB-BP483431EOO
CSB-MP483431EOO
CSB-EP483431EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Endonuclease V (nfi) CSB-YP483432EOO
CSB-EP483432EOO
CSB-BP483432EOO
CSB-MP483432EOO
CSB-EP483432EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O8 Isocitrate dehydrogenase kinase/phosphatase (aceK) CSB-YP483433EOO
CSB-EP483433EOO
CSB-BP483433EOO
CSB-MP483433EOO
CSB-EP483433EOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.practicalworld.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×